JPMorgan Chase & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536M | Buy |
4,261,747
+1,590,749
| +60% | +$200M | 0.04% | 382 |
|
|
2025
Q1 | $295M | Buy |
2,670,998
+1,299,812
| +95% | +$144M | 0.02% | 517 |
|
|
2024
Q4 | $187M | Sell |
1,371,186
-126,745
| -8% | -$17.3M | 0.01% | 634 |
|
|
2024
Q3 | $173M | Sell |
1,497,931
-864,804
| -37% | -$99.6M | 0.01% | 696 |
|
|
2024
Q2 | $325M | Buy |
2,362,735
+67,627
| +3% | +$9.31M | 0.03% | 446 |
|
|
2024
Q1 | $317M | Buy |
2,295,108
+559,565
| +32% | +$77.2M | 0.03% | 478 |
|
|
2023
Q4 | $229M | Sell |
1,735,543
-75,694
| -4% | -$9.97M | 0.02% | 536 |
|
|
2023
Q3 | $204M | Sell |
1,811,237
-150,637
| -8% | -$16.9M | 0.02% | 513 |
|
|
2023
Q2 | $185M | Sell |
1,961,874
-194,135
| -9% | -$18.3M | 0.02% | 564 |
|
|
2023
Q1 | $218M | Sell |
2,156,009
-14,053
| -0.6% | -$1.42M | 0.03% | 481 |
|
|
2022
Q4 | $259M | Sell |
2,170,062
-201,175
| -8% | -$24M | 0.03% | 405 |
|
|
2022
Q3 | $252M | Sell |
2,371,237
-626,523
| -21% | -$66.5M | 0.04% | 393 |
|
|
2022
Q2 | $292M | Sell |
2,997,760
-7,549
| -0.3% | -$736K | 0.04% | 381 |
|
|
2022
Q1 | $282M | Buy |
3,005,309
+24,210
| +0.8% | +$2.27M | 0.03% | 432 |
|
|
2021
Q4 | $254M | Buy |
2,981,099
+291,601
| +11% | +$24.8M | 0.03% | 469 |
|
|
2021
Q3 | $258M | Buy |
2,689,498
+1,242,324
| +86% | +$119M | 0.03% | 471 |
|
|
2021
Q2 | $141M | Sell |
1,447,174
-88,637
| -6% | -$8.63M | 0.02% | 696 |
|
|
2021
Q1 | $149M | Buy |
1,535,811
+582,548
| +61% | +$56.7M | 0.02% | 635 |
|
|
2020
Q4 | $91.4M | Buy |
953,263
+187,785
| +25% | +$18M | 0.01% | 744 |
|
|
2020
Q3 | $74.8M | Buy |
765,478
+43,721
| +6% | +$4.27M | 0.01% | 744 |
|
|
2020
Q2 | $88.1M | Buy |
721,757
+259,846
| +56% | +$31.7M | 0.02% | 657 |
|
|
2020
Q1 | $40M | Buy |
461,911
+418,277
| +959% | +$36.2M | 0.01% | 835 |
|
|
2019
Q4 | $4.69M | Buy |
43,634
+12,023
| +38% | +$1.29M | ﹤0.01% | 2207 |
|
|
2019
Q3 | $2.85M | Buy |
31,611
+19,953
| +171% | +$1.8M | ﹤0.01% | 2540 |
|
|
2019
Q2 | $961K | Sell |
11,658
-601,218
| -98% | -$49.6M | ﹤0.01% | 3085 |
|
|
2019
Q1 | $54M | Buy |
612,876
+349,164
| +132% | +$30.8M | 0.01% | 824 |
|
|
2018
Q4 | $18.8M | Buy |
263,712
+47,737
| +22% | +$3.41M | ﹤0.01% | 1301 |
|
|
2018
Q3 | $26.6M | Sell |
215,975
-255,355
| -54% | -$31.4M | 0.01% | 1260 |
|
|
2018
Q2 | $46.3M | Buy |
471,330
+8,720
| +2% | +$857K | 0.01% | 913 |
|
|
2018
Q1 | $38.4M | Sell |
462,610
-79,969
| -15% | -$6.63M | 0.01% | 989 |
|
|
2017
Q4 | $42.1M | Buy |
542,579
+12,331
| +2% | +$957K | 0.01% | 961 |
|
|
2017
Q3 | $31.5M | Sell |
530,248
-49,773
| -9% | -$2.96M | 0.01% | 1084 |
|
|
2017
Q2 | $26.7M | Sell |
580,021
-229,690
| -28% | -$10.6M | 0.01% | 1143 |
|
|
2017
Q1 | $35.1M | Sell |
809,711
-153,034
| -16% | -$6.63M | 0.01% | 1012 |
|
|
2016
Q4 | $37.3M | Sell |
962,745
-49,683
| -5% | -$1.92M | 0.01% | 960 |
|
|
2016
Q3 | $51.3M | Sell |
1,012,428
-234,476
| -19% | -$11.9M | 0.01% | 751 |
|
|
2016
Q2 | $56.7M | Buy |
1,246,904
+590,549
| +90% | +$26.8M | 0.01% | 717 |
|
|
2016
Q1 | $26M | Buy |
656,355
+102,630
| +19% | +$4.06M | 0.01% | 1057 |
|
|
2015
Q4 | $31.3M | Buy |
553,725
+284,827
| +106% | +$16.1M | 0.01% | 938 |
|
|
2015
Q3 | $10.7M | Sell |
268,898
-8,898
| -3% | -$354K | ﹤0.01% | 1527 |
|
|
2015
Q2 | $13.3M | Buy |
277,796
+79,823
| +40% | +$3.81M | ﹤0.01% | 1523 |
|
|
2015
Q1 | $7.86M | Buy |
197,973
+84,708
| +75% | +$3.36M | ﹤0.01% | 1853 |
|
|
2014
Q4 | $2.53M | Buy |
+113,265
| New | +$2.53M | ﹤0.01% | 2392 |
|
|
2014
Q2 | – | Sell |
-140,449
| Closed | -$2.26M | – | 3487 |
|
|
2014
Q1 | $2.26M | Buy |
140,449
+12,450
| +10% | +$200K | ﹤0.01% | 2440 |
|
|
2013
Q4 | $1.2M | Sell |
127,999
-39,117
| -23% | -$365K | ﹤0.01% | 2826 |
|
|
2013
Q3 | $1.89M | Sell |
167,116
-8,961
| -5% | -$101K | ﹤0.01% | 2619 |
|
|
2013
Q2 | $2.36M | Buy |
+176,077
| New | +$2.36M | ﹤0.01% | 2445 |
|